Clinical utility of hepatocellular carcinoma risk scores in chronic hepatitis B
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical utility of hepatocellular carcinoma risk scores in chronic hepatitis B
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 40, Issue 3, Pages 484-495
Publisher
Wiley
Online
2019-12-30
DOI
10.1111/liv.14334
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir
- (2019) Jung Hwan Yu et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- External validation of the modified PAGE ‐B score in Asian chronic hepatitis B patients receiving antiviral therapy
- (2019) Hye Won Lee et al. LIVER INTERNATIONAL
- A simple AGED score for risk classification of primary liver cancer: development and validation with long-term prospective HBsAg-positive cohorts in Qidong, China
- (2018) Chunsun Fan et al. GUT
- Long-term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e-antigen seroclearance
- (2018) James Fung et al. HEPATOLOGY
- Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis
- (2018) Suraj A. Sharma et al. JOURNAL OF HEPATOLOGY
- Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B
- (2018) Yao-Chun Hsu et al. JOURNAL OF HEPATOLOGY
- Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population
- (2018) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy
- (2018) Ji Hyun Kim et al. JOURNAL OF HEPATOLOGY
- A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels
- (2017) Dong Hyun Sinn et al. Gut and Liver
- The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
- (2017) George V. Papatheodoridis et al. HEPATOLOGY
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Prediction of long-term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE-B score
- (2017) W. P. Brouwer et al. JOURNAL OF VIRAL HEPATITIS
- Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia
- (2017) Namyoung Paik et al. LIVER INTERNATIONAL
- Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B
- (2017) Mi Young Jeon et al. LIVER INTERNATIONAL
- Validation of PAGE-B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir
- (2017) Mi Na Kim et al. LIVER INTERNATIONAL
- HCC Risk Scores: Useful or Not?
- (2017) Morris Sherman SEMINARS IN LIVER DISEASE
- Validation of risk prediction models for the development of HBV-related HCC: a retrospective multi-center 10-year follow-up cohort study
- (2017) Yeon Seok Seo et al. Oncotarget
- Real-world risk score for hepatocellular carcinoma (RWS-HCC): a clinically practical risk predictor for HCC in chronic hepatitis B
- (2016) Zhongxian Poh et al. GUT
- PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
- (2016) George Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis
- (2016) Elena Raffetti et al. LIVER INTERNATIONAL
- Utility of Prediction Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Treated with Nucleos(t)ide Analogues
- (2016) Akinobu Tawada et al. ONCOLOGY
- The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection
- (2015) Mahmoud Abu-Amara et al. GUT
- Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy
- (2015) Kyu Sik Jung et al. HEPATOLOGY
- AASLD guidelines for treatment of chronic hepatitis B
- (2015) Norah A. Terrault et al. HEPATOLOGY
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
- (2015) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?
- (2015) Vincent Wai-Sun Wong et al. JOURNAL OF HEPATOLOGY
- Prediction of Development of Liver-Related Events by Transient Elastography in Hepatitis B Patients With Complete Virological Response on Antiviral Therapy
- (2014) Hye Won Lee et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
- (2014) Pauline Arends et al. GUT
- Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis
- (2014) Seung Hwan Shin et al. LIVER INTERNATIONAL
- Liver Stiffness Is Associated With Risk of Decompensation, Liver Cancer, and Death in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis
- (2013) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Accuracy of Risk Scores for Patients With Chronic Hepatitis B Receiving Entecavir Treatment
- (2013) Grace Lai–Hung Wong et al. GASTROENTEROLOGY
- Prediction models of long-term Cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles
- (2013) Mei-Hsuan Lee et al. HEPATOLOGY
- Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B
- (2013) Grace Lai-Hung Wong et al. JOURNAL OF HEPATOLOGY
- Risk Assessment of Development of Hepatic Decompensation in Histologically Proven Hepatitis B Viral Cirrhosis Using Liver Stiffness Measurement
- (2012) Beom Kyung Kim et al. DIGESTION
- Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
- (2011) Hwai-I Yang et al. LANCET ONCOLOGY
- A Liver Stiffness Measurement-Based, Noninvasive Prediction Model for High-Risk Esophageal Varices in B-Viral Liver Cirrhosis
- (2010) Beom Kyung Kim et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
- (2010) Vincent Wai-Sun Wong et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
- (2010) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
- (2008) Man-Fung Yuen et al. JOURNAL OF HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started